Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
11 | 69642133 | intron variant | G/C;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
11 | 69648711 | intron variant | GG/-;G | delins | 0.44 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
11 | 69648911 | intron variant | A/G | snv | 5.4E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
11 | 69642779 | intron variant | C/T | snv | 9.1E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.080 | 11 | 69641336 | missense variant | G/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.080 | 11 | 69641336 | missense variant | G/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.080 | 11 | 69646918 | intron variant | C/T | snv | 1.5E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 11 | 69641374 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.925 | 0.080 | 11 | 69641374 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 |
|
0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.120 | 11 | 69639167 | upstream gene variant | C/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.120 | 11 | 69651969 | 3 prime UTR variant | C/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.925 | 0.120 | 11 | 69651969 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.925 | 0.120 | 11 | 69651969 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.925 | 0.120 | 11 | 69651969 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.120 | 11 | 69651969 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.120 | 11 | 69651347 | 3 prime UTR variant | C/A | snv | 0.44 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.120 | 11 | 69651347 | 3 prime UTR variant | C/A | snv | 0.44 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.732 | 0.440 | 11 | 69648142 | splice region variant | G/A | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||||||
|
0.732 | 0.440 | 11 | 69648142 | splice region variant | G/A | snv |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.732 | 0.440 | 11 | 69648142 | splice region variant | G/A | snv |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.732 | 0.440 | 11 | 69648142 | splice region variant | G/A | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.732 | 0.440 | 11 | 69648142 | splice region variant | G/A | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.732 | 0.440 | 11 | 69648142 | splice region variant | G/A | snv |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.732 | 0.440 | 11 | 69648142 | splice region variant | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.732 | 0.440 | 11 | 69648142 | splice region variant | G/A | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 |